161 related articles for article (PubMed ID: 21329432)
1. Profiling for novel proteomics biomarkers in neurodevelopmental disorders.
Dudley E; Hässler F; Thome J
Expert Rev Proteomics; 2011 Feb; 8(1):127-36. PubMed ID: 21329432
[TBL] [Abstract][Full Text] [Related]
2. Role of proteomics in the discovery of autism biomarkers.
Al-Ayadhi L; Halepoto DM
J Coll Physicians Surg Pak; 2013 Feb; 23(2):137-43. PubMed ID: 23374519
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's disease cerebrospinal fluid biomarker discovery: a proteomics approach.
D'Ascenzo M; Relkin NR; Lee KH
Curr Opin Mol Ther; 2005 Dec; 7(6):557-64. PubMed ID: 16372405
[TBL] [Abstract][Full Text] [Related]
4. Proteomics- and transcriptomics-based screening of differentially expressed proteins and genes in brain of Wig rat: a model for attention deficit hyperactivity disorder (ADHD) research.
Hirano M; Rakwal R; Shibato J; Sawa H; Nagashima K; Ogawa Y; Yoshida Y; Iwahashi H; Niki E; Masuo Y
J Proteome Res; 2008 Jun; 7(6):2471-89. PubMed ID: 18457438
[TBL] [Abstract][Full Text] [Related]
5. Fatty acid metabolism in neurodevelopmental disorder: a new perspective on associations between attention-deficit/hyperactivity disorder, dyslexia, dyspraxia and the autistic spectrum.
Richardson AJ; Ross MA
Prostaglandins Leukot Essent Fatty Acids; 2000; 63(1-2):1-9. PubMed ID: 10970706
[TBL] [Abstract][Full Text] [Related]
6. Attention deficit hyperactivity disorder, infantile autism, and elevated blood-lead: a possible relationship.
Eppright TD; Sanfacon JA; Horwitz EA
Mo Med; 1996 Mar; 93(3):136-8. PubMed ID: 8867271
[TBL] [Abstract][Full Text] [Related]
7. Carbohydrate-deficient transferrin does not seem to be associated with ADHD and autism.
Niederhofer H
Psychiatr Danub; 2009 Dec; 21(4):517. PubMed ID: 19935486
[No Abstract] [Full Text] [Related]
8. Urinary proteomics--a tool for biomarker discovery.
Pejcic M; Stojnev S; Stefanovic V
Ren Fail; 2010 Jan; 32(2):259-68. PubMed ID: 20199189
[TBL] [Abstract][Full Text] [Related]
9. Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample.
Simonoff E; Pickles A; Charman T; Chandler S; Loucas T; Baird G
J Am Acad Child Adolesc Psychiatry; 2008 Aug; 47(8):921-9. PubMed ID: 18645422
[TBL] [Abstract][Full Text] [Related]
10. Elevated plasma gamma-aminobutyric acid (GABA) levels in autistic youngsters: stimulus for a GABA hypothesis of autism.
Dhossche D; Applegate H; Abraham A; Maertens P; Bland L; Bencsath A; Martinez J
Med Sci Monit; 2002 Aug; 8(8):PR1-6. PubMed ID: 12165753
[TBL] [Abstract][Full Text] [Related]
11. Proteomic research in psychiatry.
Taurines R; Dudley E; Grassl J; Warnke A; Gerlach M; Coogan AN; Thome J
J Psychopharmacol; 2011 Feb; 25(2):151-96. PubMed ID: 20142298
[TBL] [Abstract][Full Text] [Related]
12. Biomarker-guided interventions of clinically relevant conditions associated with autism spectrum disorders and attention deficit hyperactivity disorder.
Bradstreet JJ; Smith S; Baral M; Rossignol DA
Altern Med Rev; 2010 Apr; 15(1):15-32. PubMed ID: 20359266
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers: unrealized potential in sports doping analysis.
Teale P; Barton C; Driver PM; Kay RG
Bioanalysis; 2009 Sep; 1(6):1103-18. PubMed ID: 21083078
[TBL] [Abstract][Full Text] [Related]
14. Combining tissue transcriptomics and urine metabolomics for breast cancer biomarker identification.
Nam H; Chung BC; Kim Y; Lee K; Lee D
Bioinformatics; 2009 Dec; 25(23):3151-7. PubMed ID: 19783829
[TBL] [Abstract][Full Text] [Related]
15. From proteomics to biomarker discovery in Alzheimer's disease.
Ho L; Sharma N; Blackman L; Festa E; Reddy G; Pasinetti GM
Brain Res Brain Res Rev; 2005 Apr; 48(2):360-9. PubMed ID: 15850675
[TBL] [Abstract][Full Text] [Related]
16. Proteomics in neurosciences.
Drabik A; Bierczynska-Krzysik A; Bodzon-Kulakowska A; Suder P; Kotlinska J; Silberring J
Mass Spectrom Rev; 2007; 26(3):432-50. PubMed ID: 17405153
[TBL] [Abstract][Full Text] [Related]
17. Functional genomics and proteomics in the clinical neurosciences: data mining and bioinformatics.
Phan JH; Quo CF; Wang MD
Prog Brain Res; 2006; 158():83-108. PubMed ID: 17027692
[TBL] [Abstract][Full Text] [Related]
18. Quantitative proteomics for investigating psychiatric disorders.
Filiou MD; Turck CW; Martins-de-Souza D
Proteomics Clin Appl; 2011 Feb; 5(1-2):38-49. PubMed ID: 21280236
[TBL] [Abstract][Full Text] [Related]
19. Genomic and proteomic profiling for biomarkers and signature profiles of toxicity.
Merrick BA; Bruno ME
Curr Opin Mol Ther; 2004 Dec; 6(6):600-7. PubMed ID: 15663324
[TBL] [Abstract][Full Text] [Related]
20. Increased urine phenylethylamine after methylphenidate treatment in children with ADHD.
Kusaga A; Yamashita Y; Koeda T; Hiratani M; Kaneko M; Yamada S; Matsuishi T
Ann Neurol; 2002 Sep; 52(3):372-4. PubMed ID: 12205654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
